Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-09

FDA Approved: BRIMONIDINE TARTRATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved the original application for Brimonidine Tartrate, a generic ophthalmic solution, enabling its sale for lowering intraocular pressure in open-a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)